Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00647439 · ClinicalTrials.gov registry record
Genetics and Markers of Degenerative and Inflammatory Eye Diseases
A clinical trial of Diabetic Retinopathy and Uveitis, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 609
- Enrollment target
- 1
- Study location
NCT00647439 is a study of Diabetic Retinopathy and Uveitis that has completed, run by National Eye Institute (NEI). The registered enrollment target is 609 participants, below the 1,666-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00647439, a study of Diabetic Retinopathy and Uveitis, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 609 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will identify genes that are associated with inflammation or degeneration of the retina (membrane lining the back of the eye that relays vision signals to the brain). It is thought that many retinal conditions are due to an altered immune system and are based on how the person s genes function and communicate. People 4 years of age or older who have a retinal condition such as uveitis, age-related macular degeneration or diabetic retinopathy may be eligible for this study. Healthy volunteers and healthy people who have a family member with one of these conditions are also eligible. Patients with inherited retinal degeneration are excluded. Participants undergo the following tests and procedures: * Eye examination to assess visual acuity (eye chart test) and eye pressure, and to examine the pupils, lenses, retina and eye movements. Photographs of the inside of the eye may also be taken. The pupils are dilated with drops for this examination. * Blood draw for genetic testing. Participants may also undergo one or more of the following tests: * Optical coherence tomography. This is a type of photograph of the back of the eye to measure thickness of the retina. * Fluorescein angiography and indocyanine green angiography. Pictures of the eye s blood vessels are taken using either a fluorescein or indocyanine green dye. The dye is injected into a vein in an arm and travels to the blood vessels in the eyes. A camera takes pictures of the dye as it flows through the blood vessels. * Electroretinogram (ERG) to measure retinal function. The patient sits in a dark room for 30 minutes with his or her eyes patched. Then, a small metal disk electrode is taped to the forehead, the eye patches are removed, the surface of the eye is numbed with eye drops, and contact lenses are placed on the eyes. The patient then watches flashing lights. The contact lenses sense small electrical signals generated by the retina when the light flashes....
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 609 participants |
| Start Date | 2008-03-27 |
| Est. Completion | 2018-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00647439
The ClinicalTrials.gov registry entry for NCT00647439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 609 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,666-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (63% lower). The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetic Retinopathy appearing as the primary indexed condition, and to 0 interventions.
NCT00647439 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00647439 about?
NCT00647439 is a clinical study titled "Genetics and Markers of Degenerative and Inflammatory Eye Diseases". This study will identify genes that are associated with inflammation or degeneration of the retina (membrane lining the back of the eye that relays vision signals to the brain). It is thought that many retinal conditions are due to an altered immune system and are based on how the person s genes fun...
What is the current status of trial NCT00647439?
This trial is currently completed. The enrollment target is 609 participants. The study started on 2008-03-27. Estimated completion is 2018-12-04.
What conditions does trial NCT00647439 study?
This clinical trial studies the following conditions: Diabetic Retinopathy, Uveitis, Age-related Macular Degeneration (AMD).
Who is sponsoring clinical trial NCT00647439?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00647439 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.